Drug profile · INN
trandolapril
DOLAPRIL 0.5
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
trandolapril (DOLAPRIL 0.5) is an FDA-listed pharmaceutical active ingredient. Associated with Alphapharm Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN trandolapril
Brand DOLAPRIL 0.5
Route ORAL
Formulation TABLET, EXTENDED RELEASE
Originator Alphapharm Pty Ltd
Frequently asked questions
What is trandolapril?
trandolapril (DOLAPRIL 0.5) is an FDA-listed pharmaceutical active ingredient. Associated with Alphapharm Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for trandolapril?
DOLAPRIL 0.5 is a marketed brand name for trandolapril. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of trandolapril?
trandolapril has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.